| Tag | Content |
|---|
EnhancerAtlas ID | HS019-11637 |
Organism | Homo sapiens |
Tissue/cell | CD20+ |
Coordinate | chr3:100333800-100335830 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Foxo1 | MA0480.1 | chr3:100334516-100334527 | TCTTGTTTACA | + | 6.02 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_28516 | chr3:100327392-100335091 | Fetal_Intestine | | SE_29227 | chr3:100327424-100335292 | Fetal_Intestine_Large |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | AATATAGGAA AATTATTATT ATCATACTGA TGTTATAAAA GAAAAATATT GCTACTAAAT 60
GTATTCCAAA ATATGGAGCC TCAAATAAAA GGAAGCTGAT GCTGCCTGTT GCAATCAATG 120
GTAAAGGCAG GCACTGTGAG GAAGGAGCAG AAGCACTTGA TCAGTTACAA GGAGGTCTGA 180
GTCTAGCACC TGCTCTGCTA CCAATTAATT ACTGATCTGG AACTAATCAC TCAGCCTTTA 240
TGTAGAATGA GGGGGTTGGG TTGATGAATA ACTAATGTCA CTTTTTTTCA AGATCATAAT 300
TCTAAAACTG GTTATATGAT ATGAACAAGC CACTTAATCT TTCTGAGTGT GACTTTCTTT 360
AGGTAAAAAT ACAGTCTTAA AGATACCAGT ACTATTTTTG CTGTATTTTG TGGGTAATTT 420
AGGTATTTCA GAGGCTAGAG TCTTGAAGTG TGTAGTACAA GGTGTTAAAC AGGTGATTGT 480
GACAGAGGAA TTGTTAGTTC AACTTGGACT AGATATCCTC AACCAAGATG CAAATGGCAA 540
AGAAGCCAGT CAGCAAATGT GTGTTGGGTA CCTTCTATTC AATGGCATTG TGCTAGGATT 600
TGAAGATATG GACCAAGACC CTTGTTCTAA AAATTGGCAA ATTACTCCTT AACTTTAAGA 660
AATGACTCTT GACTTACAGC AAAAAGACAG AAGGAGTAGA CATGGATGGA CCTCCTTCTT 720
GTTTACAAAC ATAGAAGTTA CAAATAAAAT ATGAGAATAA TTCAAATATG CAAGCAGGCT 780
TTCTTTCTTG AGGAAAAATC ACAAGTGGCA GAAATAAAGA GTAAAGTCAA CCATATGAGG 840
GGCAGCAAGC ACTGGTGCAA TTTCAATGCA TTCAGGGGGA CAGGAGGCAT GATTTCTATG 900
CTGTATGAAG CAAGGGAGCT GGACCTGAGC CACCAGCAAA ATACCTAAGC CTTGAGTAGG 960
ATCAACCAAG AAAAGAAGAT TAGAAAAATT TTACTTACTA GCCCAAAGAA GCATTAAATA 1020
ACACTATCAT CTGTTCAGAG CCATAAGTAA GGAAAAAAAA GTCACTACCA GTAATTGAAA 1080
CCCCAGGCTT TACAATCTAA ATCTGTCCTA CCTATACAGT ATTGAAATCT CCAAAAATAA 1140
TCCTAATACT AGTTCAAGAC TACTACTGAT GGTGCCCCAG GATCGTAAAA GAAGTAATCA 1200
TGAAATTTTC CTGTGGAAAT ATTTCCACAA ACAAAACCCA TAAAAGTCTC ATGGAAGAAT 1260
AATAAATAAG ACAAAGATGA GTTTACAATA CAAAATTACA TGCGAACCAT GATGCTGGAG 1320
AGACATCAGA TGTCATCAAA AGGATTAACC CTCCCAGAAT TGGATATAAC AAAACCATCT 1380
GAAAGAGAAT ATAAAATATG TTTAACAAGA TTAAGCCTTT AAAATACAGG AGAAAAATAA 1440
AAAAAGAAAA ATACAGTATT TTAAAAAGAA TAGGAGAATT TGAAAAAGAA CCAAATAATA 1500
CTTTTAAAAT AGAAAATATA GTAATGATAA AAAAATTAAT GAGTGATTTA AAAGGAGGTT 1560
AGAAATCATT AAGGTGCTGA GCATGGTGAT TCATGCCTGT ATTCCCAGCA TTTGGGAGCT 1620
CAGGCTGGAG TGTCACTTGA AGCCAAGAGT TTGAGAGCAG CCTTGGCAAC GTAGCAAGAC 1680
CTCATCTGTG CAAAACACAA AATATTATTT CAAAAATAAC CAGGCGTAGT GGCGCCTGCC 1740
TGTAGTCTCA GCTACTGGGG AGACTGTGGC AGAAGGATCC CTTGAGCCCA GGAGATGGAG 1800
GCTACAGTGA GCTATGATTA CACCTCTGCA CTCCAACCTG GGTGACAGAG GGAGATCCTG 1860
TCTCTACAAA ACAAACAAAT AAAGTCCCCC CTCCACACCC TAATAATTAC AGAGAAAACT 1920
AGGGAATGGA AAAGAAAGCT AGGAAACTGT AATTCAACAC AGTAATATAA AGAGATGTTA 1980
ACAATAATGA GATTAAAAAA TTTGATGTAT AGAAGGCTAA AGTCCAACAG 2030
|
